11 November 2019
Bioanalysis Zone announces winner of Rising Star Award 2019
Bioanalysis Zone, the knowledge hub for the bioanalytical industry, has named Zhiyu Li (WuXi AppTec; Shanghai, China) the 2019 winner of the Bioanalysis Rising Star Award (BRSA; formerly the New Investigator Award).
The BRSA is an annual award that recognizes and promotes the work of talented early-career scientists, offering researchers a springboard to help establish themselves in the exciting world of bioanalysis.
This year’s winner, Zhiyu Li, Associate Director of DMPK at WuXi AppTec and head of the company’s new capability building team, was nominated by Yi Tao (WuXi AppTec), who commented: “Zhiyu has continuously shown strong technical capabilities, an outstanding innovative mind, a constant drive for excellence, as well as strong leadership since joining our DMPK department at Lab Testing Division in WuXi AppTec in August 2016 as a Principle Scientist. As the head of our new capability building team, Zhiyu has led her team in the development of several new bioanalytical platforms, including the LC–MS-based large molecule analysis platform.”
On receiving the award, Zhiyu commented: “I am greatly honored and excited to be selected as the winner for this year’s BRSA. I would like to thank the award sponsors, Waters Corporation, Bioanalysis Zone and all my family, friends and colleagues for their votes and support.”
As the winner of the BRSA, Zhiyu will present her work at the 12th European Bioanalysis Forum (EBF) Open Symposium, in Barcelona, Spain on 21 November 2019. She also receives a 1-year subscription to Bioanalysis and US $1000, courtesy of award sponsors Waters Corporation (MA, USA), a leading provider of laboratory solutions and software in separations science, mass spectrometry and thermal analysis.
Naamah Maundrell, Senior Editor of Bioanalysis Zone, added: “As always it has been a privilege to coordinate the BRSA award and to get to know amazing scientists. I would like to congratulate Zhiyu and all of this year’s nominees on their inspiring research.”
Zhiyu won the public vote after six finalists were shortlisted by the judges. The other finalists were Justin Mak (Stanford Health Care; CA, USA), Kruthika Sundaram (Viapath Analytics; London, UK), Lee Andrews (Syneos Health; NC, USA), Sebastien Boridy (Charles River Laboratories; MA, USA) and Xiaoyu Wang (Nanjing University, China).
Videos introducing the research of each finalist are available to view at www.bioanalysis-zone.com/awards.
Nominations are now being accepted for the 2020 Bioanalysis Rising Star Award – contact the Senior Editor Naamah Maundrell directly (firstname.lastname@example.org) to submit a nomination.
Further details on the EBF 12th Open Symposium can be found here.
About Bioanalysis Zone
Since launching in 2011, Bioanalysis Zone has attracted over 11,000 active members from the global bioanalytical community, representing the pharmaceutical, biotech and CRO industries, along with academia and healthcare. Each month, thousands of members visit the site to read industry news, original research, exclusive interviews, webinars and commentaries. Join the Bioanalysis Zone Twitter and LinkedIn group for updates.
About Waters Corporation
Waters Corporation develops and manufactures advanced analytical and material science technologies for laboratory-dependent organizations. For more than 50 years, the company has pioneered a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis systems.
About Future Science Group
Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG’s portfolio consists of three publishing imprints, Future Science, Future Medicine and Newlands Press, as well as a content development imprint, PharmaPlatforms. In addition to a core business of subscription and open access journal publishing, FSG develops specialist knowledge networks and content hubs, such as Bioanalysis Zone, enabling professionals to easily connect and collaborate with their peers in niche scientific fields.
The aim of Future Science Group is to serve the advancement of clinical practice and drug research by enhancing the efficiency of communication among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. www.future-science-group.com